申请人:——
公开号:US20030225068A1
公开(公告)日:2003-12-04
A pharmaceutical compound of the formula (I) in which R
1
and R
2
are each hydrogen or C
1-6
alkyl, R
3
is —SR
10
, —SOR
10
, —SO
2
R
10
, —COR
10
, —CH
2
OH or —CONHR
11
, where R
10
is C
1-6
alkyl and R
11
is hydrogen or C
1-6
alkyl, R
4
, R
5
, R
6
and R
7
are each hydrogen or C
1-6
alkyl, provided that at least one of R
4
, R
5
, R
6
and R
7
is C
1-6
alkyl, R
8
and R
9
are each hydrogen, halo, C
1-6
alkyl or cyano, n is 0 or 1 and m is 2 or 3, x is a (a) or (b), and y is (c) or (d), wherein R
12
and R
13
are each hydrogen, C
1-
alkyl, cyclopropyl or cyclopropyl-C
1-6
alkyl; and salts thereof.
1
化学式(I)中的一种药物化合物,其中R1和R2分别为氢或C1-6烷基,R3为—SR10,—SOR10,—SO2R10,—COR10,—CH2OH或—CONHR11,其中R10为C1-6烷基,R11为氢或C1-6烷基,R4、R5、R6和R7分别为氢或C1-6烷基,但至少其中之一为C1-6烷基,R8和R9分别为氢、卤素、C1-6烷基或氰基,n为0或1,m为2或3,x为(a)或(b),y为(c)或(d),其中R12和R13分别为氢、C1-烷基、环丙基或环丙基-C1-6烷基;及其盐。